Publications by authors named "G G Meshram"
Background: Adverse events following immunization (AEFI) must be reported and assessed to promote patient safety. This longitudinal study examined the nature and severity of adverse events reported after Covishield (Serum Institute of India, Pune, India) vaccine administration to North Indians in a tertiary care hospital.
Method: A retrospective evaluation of adverse drug reactions (ADRs) reported after Covishield vaccine administration in our hospital over 18 months was conducted.
Purpose: To observe the variability in the plasma concentrations and pharmacokinetic-pharmacodynamic (PK-PD) profiles of first-line antitubercular drugs in pulmonary tuberculosis (TB) patients with and without diabetes mellitus (DM).
Methods: Newly diagnosed pulmonary TB patients aged 18-60 years with or without DM were included in the study. Group I (n = 20) included patients with TB, whereas group II (n = 20) included patients with both TB and DM.
Article Synopsis
- The study addresses the lack of research on hematological health in reproductive-age women in India and aims to establish normative ranges for various blood parameters.
- A total of 472 clinically healthy women, aged 18-40, were analyzed to generate new hematological reference intervals, which differ significantly from existing values.
- Key findings indicate that women's blood parameters did not vary significantly by age, geography, or ethnicity but showed correlations with insulin resistance, highlighting potential health issues that require further investigation.
Background: Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders largely affecting women of reproductive age group.
Objectives: This study aimed to understand the Indian public health-care systems' preparedness in addressing PCOS.
Materials And Methods: A multicentric rapid assessment cross-sectional study was undertaken among 173 health-care providers serving across various public health-care facilities in India.
Objectives: Single dose prophylaxis is good enough for general surgery with low risk patients. However, the evidence for the effectiveness of single dose anti-microbial prophylaxis (AMP) is not conclusive in high risk patients and spinal surgeries requiring instrumentation or the use of implants in particular. No studies have explored the various concentration of ceftriaxone in plasma and tissue as well during an ongoing spinal surgery.
View Article and Find Full Text PDF